Stryker SYK
NYSE SYK
$275.50 -0.93 (-0.34%)
As of: Sep 9, 2026 · 3:59 PM EDT

Stryker (SYK) Cash from Financing Activities (2009 - 2026)

Stryker's (SYK) quarterly Cash from Financing Activities came in at -$95.0 million in Q2 2026, up 90.39% year-over-year from -$49.9 million in Q2 2025, and up 93.71% quarter-over-quarter from -$1.5 billion in Q1 2026.

Analysis

Stryker (SYK) Cash from Financing Activities (2009 - 2026) Analysis & Trends

Stryker (SYK) has reported Cash from Financing Activities for 18 consecutive years, with -$95.0 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Cash from Financing Activities rose 90.39% year-over-year to -$95.0 million in Q2 2026; TTM through Jun 2026 was -$3.0 billion, a 226.33% decrease from a year earlier, with the FY2025 full-year figure at $113.0 million, up 121.52% from the prior year.
  • Cash from Financing Activities was -$95.0 million for Q2 2026 at Stryker, up from -$1.5 billion in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $2.7 billion in Q3 2024 and troughed at -$1.8 billion in Q4 2024.
  • A 5-year average of -$242.2 million and a median of -$434.0 million in 2022 frame the typical range for Cash from Financing Activities.
  • The widest YoY moves for Cash from Financing Activities: up 728.67% in 2024, down 527.27% in 2024.
  • Over 5 years, Cash from Financing Activities stood at -$446.0 million in 2022, then surged by 35.87% to -$286.0 million in 2023, then slumped by 527.27% to -$1.8 billion in 2024, then surged by 39.07% to -$1.1 billion in 2025, then soared by 91.31% to -$95.0 million in 2026.
  • The last three Cash from Financing Activities figures came in at -$95.0 million (Q2 2026), -$1.5 billion (Q1 2026), and -$1.1 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn -3.52 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn -287.90 Mn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn -343.00 Mn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn -95.00 Mn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn -410.00 Mn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn -300,000.00
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -510.00 Mn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn -607.30 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn -213.50 Mn
10 Zimmer Biomet Holdings 18.20 Bn 17.79 Bn 1.54 Bn -271.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -95.00 Mn
Mar 31, 2026 -1.51 Bn
Dec 31, 2025 -1.09 Bn
Sep 30, 2025 -339.00 Mn
Jun 30, 2025 -989.00 Mn
Mar 31, 2025 2.53 Bn
Dec 31, 2024 -1.79 Bn
Sep 30, 2024 2.65 Bn
Jun 30, 2024 -966.00 Mn
Mar 31, 2024 -418.00 Mn
Dec 31, 2023 -286.00 Mn
Sep 30, 2023 -422.00 Mn
Jun 30, 2023 -405.00 Mn
Mar 31, 2023 -481.00 Mn
Dec 31, 2022 -446.00 Mn
Sep 30, 2022 -543.00 Mn
Jun 30, 2022 -753.00 Mn
Mar 31, 2022 993.00 Mn
Dec 31, 2021 -288.00 Mn
Sep 30, 2021 -348.00 Mn